相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
Dan Turner et al.
GASTROENTEROLOGY (2021)
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
Hiroshi Nakase et al.
JOURNAL OF GASTROENTEROLOGY (2021)
Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial
Taku Kobayashi et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Clinical outcome after anti-tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long-term study
Maria Jose Casanova et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
Ulcerative colitis
Taku Kobayashi et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Practical guidance for the management of inflammatory bowel disease in patients with cancer. Which treatment?
Shaji Sebastian et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)
The Gastric Acid Pocket (or Coat) and Its Attenuation in Helicobacter pylori-infected Subjects
Kenneth E. L. McColl
JOURNAL OF CLINICAL GASTROENTEROLOGY (2018)
European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ['Exit Strategies'] in Inflammatory Bowel Disease
Glen Doherty et al.
JOURNAL OF CROHNS & COLITIS (2018)
Optimized thiopurine therapy before withdrawal of anti-tumour necrosis factor- in patients with Crohn's disease
Sandra Bohn Thomsen et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study
Yoichi Kakuta et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study
M. J. Casanova et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNF-blocking agents
Pauliina Molander et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation
Martin Bortlik et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2016)
Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis
Tariq Ahmad et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
The Risk of Relapse after Anti-TNF Discontinuation in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Javier P. Gisbert et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study
Gionata Fiorino et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials
V. Jairath et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Undetectable anti-TNF drug levels in patients with long-term remission predict successful drug withdrawal
S. Ben-Horin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
Joana Torres et al.
GASTROENTEROLOGY (2015)
Leukopenia Predicts Remission in Patients with Inflammatory Bowel Disease and Behcet's Disease on Thiopurine Maintenance
Mi Sung Park et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Review article: why, when and how to de-escalate therapy in inflammatory bowel diseases
B. Pariente et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2014)
Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study
Cloe Charpentier et al.
GUT (2014)
Mucosal Healing Did Not Predict Sustained Clinical Remission in Patients with IBD after Discontinuation of One-Year Infliximab Therapy
Cong Dai et al.
PLOS ONE (2014)
Frequency and prognostic role of mucosal healing in patients with Crohn's disease and ulcerative colitis after one-year of biological therapy
Klaudia Farkas et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials
Alexander C. Ford et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Comparison of demographic and clinical characteristics of patients with early vs. adult vs. late onset ulcerative colitis
Ismail Hakki Kalkan et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2013)
Predictors of relapse in patients with ulcerative colitis in remission after one-year of infliximab therapy
Klaudia Farkas et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease
Millie D. Long et al.
GASTROENTEROLOGY (2012)
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2012)
Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study
Casper Steenholdt et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Clinical implications of mucosal healing for the management of IBD
Guillaume Pineton de Chambrun et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Maintenance of remission with infliximab in inflammatory bowel disease: Efficacy and safety long-term follow-up
Renato Caviglia et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Mark S. Silverberg et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
分享论文
